|
||||||||||||||||||||
 |
||||||||||||||||||||
|
||||||||||
|
|
acridine carboxamide A tricyclic acridine-based (or carboxamide-based) drug with dual topoisomerase inhibitor and potential antineoplastic activities. Acridine carboxamide inhibits both topoisomerases I and II and intercalates into DNA, resulting in DNA damage, the disruption of DNA repair and replication, the inhibition of RNA and protein synthesis, and cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
|
|
|||||||||||||||||||||
|
|
|
NCI Home |
Text-Only Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
A Service of the National Cancer Institute |
|
 |
|
